AzTrials
AzTrials

Perinatal Mental HealthNCT06467916

The Development of PATH, a Program to Support NICU Parent Mental Health Through the Transition From Hospital to Home

A study testing Behavioral Treatment in people with Perinatal Mental Health, run by University of Colorado, Denver at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to develop and pilot test a telehealth-based mental health screening and engagement program that supports parents as their infants transition home from the NICU. Read more about this study

Who is it for?
Any age
Conditions the study is for
Perinatal Mental Health
What is being tested?
Behavioral Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
2 sitesUnited States
Study dates
22 Apr 2025to 30 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • NICU parents: Participants will be parents of currently hospitalized preterm infants from either the OHSU NICU or the UCH NICU. We will include parents of live preterm infants who have been admitted in the NICU for at least 2 weeks. Parents must speak English or Spanish. Parents can be of any age.
  • NICU stakeholders: Participants will be stakeholders from either the OHSU NICU or the UCH NICU. Stakeholders will be social workers, mental health providers responsible for providing more intensive mental health support for NICU parents, nurses, neonatologists, and hospital administrators.

Who cannot join

None listed.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Susanne Klawetter, PhD contact

303-724-1646

susanne.klawetter@cuanschutz.edu

Sunah S Hwang, MD, PhD, MPH/MSPH contact

720-848-0000

sunah.hwang@childrenscolorado.org

United States2 sites, 2 recruiting
  • University of Colorado Hospital

    Aurora, Colorado, 80045

    Susanne Klawetter, PhD, 303-724-1646, susanne.klawetter@cuanschutz.edu

    Sunah S Hwang, MD, PhD, MPH/MSPH, 720-848-0000, sunah.hwang@childrenscolorado.org

    Recruiting
  • Oregon Health & Science University

    Portland, Oregon, 97239

    Cindy McEvoy, MD,MCR, 503-494-8122, mcevoyc@ohsu.edu

    Susanne Klawetter, PhD, 303-724-1646, susanne.klawetter@cuanschutz.edu

    Recruiting

Other trials in United States

About this study

The objective of this study is to develop and pilot test a telehealth-based mental health screening and engagement program that supports parents as their infants transition home from the NICU. The program will use a stepped-care approach to screen parents for depression, anxiety, and PTSD; provide a brief behavioral intervention to those who screen as having at least a low risk of these conditions; and provide a warm hand-off to community mental health services for those at medium to high risk.

Being tested
Behavioral Treatment
Keywords
neonatal intensive care unit, perinatal mental health, perinatal depression, perinatal anxiety, posttraumatic stress disorder
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral TreatmentBehavioural

    anticipatory guidance, brief behavioral intervention, or referral to community mental health provider

Study groups in NCT06467916
Study groupRoleWhat they receive
InterventionExperimentalanticipatory guidance, brief behavioral intervention, or referral to community mental health provider
Receives: Behavioral: Behavioral Treatment
ControlNo interventionusual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mental health self-efficacy scale

    Mental health self-efficacy

    Measured: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

Secondary outcomes (2)
  1. City Mental Illness Stigma Scale

    Mental illness stigma

    Measured: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

  2. Parenting Sense of Self Confidence Scale

    Parenting self-efficacy

    Measured: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2024
  2. Study start22 Apr 2025 (estimated)
  3. Primary completion1 Apr 2026 (estimated)
  4. Study completion30 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06467916
Sponsor's protocol ID
23-1191
Other IDs
K08MH127519
Status last verified
Apr 2025
First submitted
14 Jun 2024
Last updated
24 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Project data and materials will be administered in accordance with both participating institutional and NIH policies, including the NICH Data Sharing Policy and Implementation Guidance of March 5, 2003. Depending on such policies, materials may be transferred to others under the terms of material transfer agreement. Data, including survey instruments and datasets, will be available approximately one year after study completion. Researchers can contact the research staff to request access to datasets and support for their use. Publication of data shall occur during the project, if appropriate, or at the end of the project, consistent with normal scientific practices. The final locked dataset will be stripped of all participant identifiers. This dataset will be available to the nonprofit community for noncommercial uses provided that a data-sharing agreement is reached and that the original creators of the dataset are able to collaborate in all secondary data analysis.

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral Treatment in people with Perinatal Mental Health, run by University of Colorado, Denver at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Susanne Klawetter, PhD (303-724-1646, susanne.klawetter@cuanschutz.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mental health self-efficacy scale (time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in